SCHEMBL1638772

SCHEMBL1638772

NNC(=O)c1ccc2ccccc2c1O

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LDHA P00338 1/20 0.65
MEN1 O00255 7/20 0.62
KMT2A Q03164 7/20 0.62
MAPT P10636 3/20 0.62
KDM4E B2RXH2 2/20 0.62
LMNA P02545 1/20 0.62
HTT P42858 1/20 0.62
PLG P00747 2/20 0.61
KLK1 P06870 2/20 0.61
KLK6 Q92876 2/20 0.61
NPC1 O15118 2/20 0.59
RAB9A P51151 2/20 0.59
KDM4A O75164 1/20 0.59
CTDSP1 Q9GZU7 1/20 0.59
KDM4C Q9H3R0 1/20 0.59
GAA P10253 2/20 0.57
ALDH1A1 P00352 1/20 0.57
NPSR1 Q6W5P4 1/20 0.57
RXFP1 Q9HBX9 1/20 0.57
MITF O75030 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18422008 0.85 LDHA (0.65) LDHAMEN1KMT2AMAPTKDM4E
SCHEMBL31094235 0.85 LDHA (0.65) LDHAMEN1KMT2AMAPTKDM4E
SCHEMBL10724439 0.85 LDHA (0.65) LDHAMEN1KMT2AMAPTKDM4E
SCHEMBL5667713 0.84 MEN1 (0.60) LDHAMEN1KMT2AMAPTKDM4E
SCHEMBL11507636 0.84 LDHA (0.62) LDHAMEN1KMT2AMAPTKDM4E
SCHEMBL856182 0.84 MAPT (0.50) LDHAMEN1KMT2AMAPTKDM4E
SCHEMBL7192236 0.84 PLK1 (0.66) LDHAMEN1KMT2AMAPTKDM4E
SCHEMBL11102639 0.82 PLG (0.58) LDHAMEN1KMT2AMAPTKDM4E
Hydrochloric Acid SCHEMBL10957126 0.82 PLG (0.58) LDHAMEN1KMT2AMAPTKDM4E
SCHEMBL145153 0.81 HDAC8 (0.69) MEN1KMT2AMAPTLMNANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999001607-A2 ENZYMATIC OXIDATION SYSTEM WITH NOVEL ENZYMATIC-EFFECT ENHANCING COMPOUNDS CALL, KRIMHILD (DE) 1999-01-14 WO claimed
EP-4169736-B1 RUBBER COMPOSITION AND TIRE BRIDGESTONE CORP (JP) 2024-11-27 EP disclosed
CN-115702200-B Rubber composition and tire 株式会社普利司通 2024-07-30 CN disclosed
US-20240131356-A1 COMBINATION OF INTRACELLULAR AND EXTRACELLULAR PHOTOSENSITIZERS FOR TREATMENT OF BACTERIAL INFECTION VANDERBILT UNIVERSITY 2024-04-25 US disclosed
EP-4284912-A1 COMBINATION OF INTRACELLULAR AND EXTRACELLULAR PHOTOSENSITIZERS FOR TREATMENT OF BACTERIAL INFECTION Vanderbilt University (US) 2023-12-06 EP disclosed
US-20230312882-A1 RUBBER COMPOSITION AND TIRE BRIDGESTONE CORPORATION (JP) 2023-10-05 US disclosed
WO-2023132214-A1 CURABLE COMPOSITION AND CURED PRODUCT 株式会社カネカ 2023-07-13 WO disclosed
WO-2023095850-A1 STEEL CORD-RUBBER COMPOSITE, MANUFACTURING METHOD FOR STEEL CORD-RUBBER COMPOSITE, AND TIRE 株式会社ブリヂストン 2023-06-01 WO disclosed
EP-4169736-A1 RUBBER COMPOSITION AND TIRE BRIDGESTONE CORPORATION (JP) 2023-04-26 EP disclosed
CN-115702200-A Rubber composition and tire 株式会社普利司通 2023-02-14 CN disclosed
US-20020128292-A1 Substituted indole-2-carboxylic acid benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof CYTOVIA, INC. 2002-09-12 US disclosed
US-20020077423-A1 Polymaleimide-containing rubber composition and tire BRIDGESTONE CORPORATION 2002-06-20 US disclosed
US-6380288-B1 LOW HEAT GENERATION PROPERTY, AGING REISTANCE, ALSO FOR PRODUCING VIBRATION ISOLATORS, BELTS AND HOSES AS WELL AS TIRE MATERIALS SUCH AS TIRE TREADS, UNDERTREADS, CARCASSES, SIDE WALLS AND BEADS BRIDGESTONE CORPORATION 2002-04-30 US disclosed
EP-1199331-A1 Polymaleimide-containing rubber composition and tire BRIDGESTONE CORPORATION (JP) 2002-04-24 EP disclosed
EP-1095972-A1 Rubber composition and tire Bridgestone Corporation (JP) 2001-05-02 EP disclosed
EP-1083199-A1 RUBBER COMPOSITION AND PNEUMATIC TIRE BRIDGESTONE CORPORATION (JP) 2001-03-14 EP disclosed
EP-0998946-A1 Non-porphyrin compound for use as a diagnosticum and/or pharmaceutical K.U. LEUVEN RESEARCH & DEVELOPMENT (BE) 2000-05-10 EP disclosed
WO-2000009169-A1 NON-PORPHYRIN COMPOUND FOR USE AS A DIAGNOSTICUM AND/OR PHARMACEUTICAL K.U. LEUVEN RESEARCH & DEVELOPMENT (BE) 2000-02-24 WO disclosed
EP-0909788-A1 RUBBER COMPOSITION AND PNEUMATIC TIRES Bridgestone Corporation (JP) 1999-04-21 EP disclosed
WO-1999001607-A2 ENZYMATIC OXIDATION SYSTEM WITH NOVEL ENZYMATIC-EFFECT ENHANCING COMPOUNDS CALL, KRIMHILD (DE) 1999-01-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020128292-A1 Substituted indole-2-carboxylic acid benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof BAD, API5, CASP2 LDHA 595/4885MEN1 2427/4885KMT2A 2064/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.